The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

European regulators have greenlit a twice-yearly injection to prevent HIV that has been hailed as a game-changer in the ...

Gilead Sciences (NASDAQ:GILD) announced on Friday that the European Medicines Agency’s Committee for Medicinal Products for ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

Researchers say findings point to gaps in prenatal HIV detection; the majority of infants not treated for HIV infection after birth were Black.

Northwell Health is now offering a new injection that promises to reduce the risk of HIV and AIDS. Doctors say it will combat ...

Gilead on Friday said the recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use covers lenacapavir for use as pre-exposure prophylaxis, or PrEP, to reduce ...

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...

Arizona organizations are working hard to provide testing and education for HIV/AIDS programs, but despite medical ...

The Kilimanjaro Regional Commissioner, Mr Nurdin Babu, has called on the public—especially young people—to remain vigilant in ...

When Robert Smith met his future girlfriend in 2010, he wanted to take things slowly. For Smith, no relationship had been ...